OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Shuxuan Huang, Zhi Chen, Binglin Fan, et al.
Journal of Neuroimmunology (2021) Vol. 354, pp. 577543-577543
Closed Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress
Xenia Abadin, Cristina de Dios, Marlene Zubillaga, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1440-1440
Open Access | Times Cited: 2

MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal α-synuclein accumulation
Yu Ren, Qing Wang, Ze-xian Yang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 611, pp. 23-30
Closed Access | Times Cited: 12

Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses
Liping Zhou, Xingzhe Wang, Xueyao Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113535-113535
Closed Access | Times Cited: 11

Microbiome Alterations and Alzheimer’s Disease: Modeling Strategies with Transgenic Mice
Juan Antonio López-Villodres, Alejandro Escamilla, Silvia Mercado-Sáenz, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1846-1846
Open Access | Times Cited: 6

Benfotiamine protects MPTP-induced Parkinson’s disease mouse model via activating Nrf2 signaling pathway
Kai Wang, Chao Han, Jinwei Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307012-e0307012
Open Access | Times Cited: 1

Neuroinflammation-mediated white matter injury in Parkinson’s disease and potential therapeutic strategies targeting NLRP3 inflammasome
Linglong Xiao, Mengqi Wang, Yifeng Shi, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113483-113483
Closed Access | Times Cited: 1

Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Nataša Kuštrimović, Sahar Balkhi, Giorgia Bilato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12164-12164
Open Access | Times Cited: 1

Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis
Aishwarya Mary Johnson, Zhen-Yi Andy Ou, Richard D. Gordon, et al.
The International Journal of Biochemistry & Cell Biology (2021) Vol. 142, pp. 106113-106113
Closed Access | Times Cited: 11

Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”
Eduardo A. Albornoz, Richard D. Gordon, Vinod Kumar, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Open Access | Times Cited: 2

Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia
Hiu Chuen Lok, Jared S. Katzeff, John R. Hodges, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2

A review of studies on the implication of NLRP3 inflammasome for Parkinson’s disease and related candidate treatment targets
Nannan Zeng, Qi Wang, Chong Zhang, et al.
Neurochemistry International (2023) Vol. 170, pp. 105610-105610
Closed Access | Times Cited: 2

Emerging targets signaling for inflammation in Parkinson’s disease drug discovery
Rhema Chandan Khairnar, Niraj Parihar, Kedar S. Prabhavalkar, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 7, pp. 2143-2161
Closed Access | Times Cited: 1

Inflammasome and neurodegenerative diseases
Kishore Aravind Ravichandran, Michael T. Heneka
Elsevier eBooks (2022), pp. 291-326
Closed Access | Times Cited: 1

NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease
Yutong Chen, Weicheng Meng, Guang‐Ming Ren, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18038-e18038
Open Access

Previous Page - Page 2

Scroll to top